G
GKB Ophthalmics Ltd
BSE:533212
GKB Ophthalmics Ltd
BSE:533212
Price:
56.29
INR
-4.37%
Market Cap:
₹283.7m
Balance Sheet
Balance Sheet Decomposition
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd
Balance Sheet Decomposition is not available for
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd
Balance Sheet
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd
Currency: INR
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
132
|
60
|
59
|
24
|
32
|
30
|
|
| Cash |
0
|
60
|
59
|
24
|
32
|
30
|
|
| Cash Equivalents |
132
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
1
|
6
|
6
|
17
|
2
|
5
|
|
| Total Receivables |
276
|
198
|
199
|
277
|
284
|
255
|
|
| Accounts Receivables |
249
|
195
|
195
|
277
|
284
|
255
|
|
| Other Receivables |
27
|
3
|
4
|
0
|
0
|
0
|
|
| Inventory |
304
|
354
|
377
|
387
|
400
|
504
|
|
| Other Current Assets |
15
|
122
|
114
|
130
|
157
|
200
|
|
| Total Current Assets |
728
|
740
|
755
|
835
|
875
|
994
|
|
| PP&E Net |
256
|
242
|
261
|
230
|
221
|
209
|
|
| Intangible Assets |
7
|
7
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
4
|
3
|
1
|
|
| Long-Term Investments |
12
|
18
|
20
|
20
|
18
|
21
|
|
| Other Long-Term Assets |
19
|
60
|
66
|
34
|
28
|
27
|
|
| Total Assets |
1 023
N/A
|
1 068
+4%
|
1 102
+3%
|
1 123
+2%
|
1 145
+2%
|
1 252
+9%
|
|
| Liabilities | |||||||
| Accounts Payable |
238
|
238
|
256
|
238
|
331
|
393
|
|
| Accrued Liabilities |
5
|
11
|
13
|
0
|
0
|
0
|
|
| Short-Term Debt |
151
|
103
|
96
|
96
|
100
|
95
|
|
| Current Portion of Long-Term Debt |
0
|
9
|
5
|
4
|
4
|
19
|
|
| Other Current Liabilities |
20
|
29
|
26
|
74
|
27
|
117
|
|
| Total Current Liabilities |
414
|
381
|
396
|
413
|
462
|
624
|
|
| Long-Term Debt |
0
|
10
|
16
|
12
|
11
|
31
|
|
| Deferred Income Tax |
5
|
2
|
2
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
37
|
43
|
46
|
44
|
44
|
|
| Other Liabilities |
11
|
12
|
13
|
25
|
30
|
33
|
|
| Total Liabilities |
430
N/A
|
442
+3%
|
471
+7%
|
496
+5%
|
547
+10%
|
732
+34%
|
|
| Equity | |||||||
| Common Stock |
50
|
50
|
50
|
50
|
50
|
50
|
|
| Retained Earnings |
542
|
576
|
581
|
577
|
547
|
470
|
|
| Total Equity |
593
N/A
|
627
+6%
|
631
+1%
|
627
-1%
|
598
-5%
|
520
-13%
|
|
| Total Liabilities & Equity |
1 023
N/A
|
1 068
+4%
|
1 102
+3%
|
1 123
+2%
|
1 145
+2%
|
1 252
+9%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
